Glad to see that our work on using nanoparticle-based ON-OFF switches for CAR-T cells therapy against solid tumors is getting positive traction in the local media. Here is my interview with Kylie Veleta of Inside Indiana business on what motivates us to keep pushing forward. The website is Indiana business focused. The interview was part …
Category Archive: Immunotherapy
Nov 05
Dual Mode CT/Fluorescence Detectable Immunotargeted Nanoparticle Probes to Identify Self-Renewing Cancer Cells In Vivo
Statement of Purpose: The high mortality and poor prognosis for women diagnosed with ovarian cancer is mainly due to late diagnosis. Improved detection of primary tumors and recurring tumors after chemotherapy is, therefore, crucial to reduce ovarian cancer mortality and improve progression-free survival. However, current clinical screening and diagnostic imaging methods are limited by low …
NIH Funding Opportunities
- Notice of Budget Change in RFA-AI-24-006 Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial Not Allowed) April 25, 2024Notice NOT-AI-24-046 from the NIH Guide for Grants and Contracts
- Engineering Durable HIV Vaccine Responses (ENDURE) (R01 Clinical Trial Not Allowed) April 25, 2024Funding Opportunity RFA-AI-24-025 from the NIH Guide for Grants and Contracts. The purpose of this Notice of Funding Opportunity (NOFO) is to support basic and applied research to understand and improve durable immune responses to candidate HIV vaccines.
- Notice to Update PAR-23-194, "Substance Use/Substance Use Disorder Dissertation Research Award (R36 Clinical Trials Not Allowed)" April 25, 2024Notice NOT-DA-24-030 from the NIH Guide for Grants and Contracts
- Notice of Change to Key Date Section in PAR-24-080, Limited Competition: Revision Applications of Existing NIH Centers for AIDS Research (CFAR) and Developmental Centers for AIDS Research (D-CFAR) Grants (P30 Clinical Trial Not Allowed) April 25, 2024Notice NOT-AI-24-035 from the NIH Guide for Grants and Contracts
- Notice to Extend PAR-22-027, "Mechanism for Time-Sensitive Drug Abuse Research (R21 Clinical Trial Optional)" April 25, 2024Notice NOT-DA-24-025 from the NIH Guide for Grants and Contracts
- Understanding the Intersection of Social Inequities to Optimize Health and Reduce Health Disparities: The Axes Initiative (R01 Clinical Trial Optional) April 25, 2024Funding Opportunity RFA-NR-24-006 from the NIH Guide for Grants and Contracts. Research shows that intersecting systems of privilege and oppression produce and sustain wide and unjust variations in health. The Axes Initiative will support research to understand health at the intersections of social statuses such as race, ethnicity, socioeconomic status, sexual orientation, and ability, by […]
- Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Not Allowed) April 25, 2024Funding Opportunity PA-24-188 from the NIH Guide for Grants and Contracts. The purpose of the NIH Midcareer Investigator Award in Patient-Oriented Research (K24) is to provide support to mid-career health-professional doctorates for protected time to devote to patient-oriented research (POR) and to act as research mentors primarily for clinical residents, clinical fellows and/or junior clinical […]
- Midcareer Investigator Award in Patient-Oriented Research (Parent K24 Independent Clinical Trial Required) April 25, 2024Funding Opportunity PA-24-187 from the NIH Guide for Grants and Contracts. The purpose of the NIH Midcareer Investigator Award in Patient-Oriented Research (K24) is to provide support to mid-career health-professional doctorates for protected time to devote to patient-oriented research (POR) and to act as research mentors primarily for clinical residents, clinical fellows and/or junior clinical […]
- Midcareer Investigator Award in Patient-Oriented Research (Parent K24 - Independent Basic Experimental Studies with Humans Required) April 25, 2024Funding Opportunity PA-24-189 from the NIH Guide for Grants and Contracts. The purpose of the NIH Midcareer Investigator Award in Patient-Oriented Research (K24) is to provide support to mid-career health-professional doctorates for protected time to devote to patient-oriented research (POR) and to act as research mentors primarily for clinical residents, clinical fellows and/or junior clinical […]
- Notice of Participation of NIMH in PAR-23-309 "Health and Health Care Disparities Among Persons Living with Disabilities (R01 - Clinical Trials Optional)" April 24, 2024Notice NOT-MH-24-245 from the NIH Guide for Grants and Contracts
Recent Comments